2023年12月14日 · The 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG) is a voluntary agreement between the Department of Health and Social Care (DHSC), …

2023年11月20日 · The 2024 voluntary scheme for branded medicines pricing, access, and growth (VPAG) Life Sciences Investment Programme is a new joint government-industry programme …

2024年11月7日 · As part of transparency data, the Department of Health and Social Care (DHSC) – the government agency responsible for managing the scheme – published on the 4th …

2024 Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) Promoting better patient outcomes and a healthier population. Contributing to a financially sustainable NHS. …

The 2024 Voluntary scheme for branded medicines pricing, access and growth (2024 Voluntary Scheme) will come into force on 1 January 2024, following expiry of the 2019 Voluntary …

2023年11月22日 · The 2024 voluntary scheme for branded medicines pricing, access and growth (“VPAG”) provides for accelerated growth of the NHS’s annual branded medicines spend, …

2024年10月22日 · The 2024 Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) is designed to ensure NHS patients can access the best available clinically proven …

2023年12月14日 · The full text of the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG) has been published by the Department of Health and Social Care …

2024年12月16日 · The 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG) is a voluntary agreement between the Department of Health and Social Care (DHSC), …

2024年11月7日 · Whilst not explicit, it does appear that the Department of Health and Social Care (DHSC), which operates the VPAG, are also the ones who do the work to produce the metrics, …